Nowadays, most drugs used in the treatment of osteoporosis reduce the risk of suffering new fractures by approximately 50–60%. No one treatment can remove all risk. New Assessment Tools for ...

However, there is a problem facing the treatment of osteoporosis, and it is the lack of research into new therapies, leading to a limited pipeline of new treatments coming through. In the UK ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune ...

Caring for a child with osteoporosis can be challenging, as it requires understanding a complex condition, managing ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov ... serve as diagnostic tools and potential targets for treatments. Drawing from a large database of ...

A breakthrough in Taiwan could mean earlier diagnosis and personalized treatment for those suffering from arthritis and ...

Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and potential targets for ...

Patients have told ABC NEWS they're concerned about a lack of informed consent over Australia's most common osteoporosis drug ...

Because there are typically no symptoms until the first fracture occurs, osteoporosis is considered a silent disease. Some call it a silent killer. Osteoporosis is a bone disease characterized by ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by ...

JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today reported ...